The latest trading session saw Humacyte, Inc. (HUMA) ending at $1.45, denoting a +1.4% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.15% for the day. Meanwhile, the Dow gained 0.35%, and the Nasdaq, a tech-heavy index, lost 0.09%.The the stock of company has fallen by 4.03% in the past month, leading the Medical sector's loss of 4.39% and undershooting the S&P 500's loss of 0.21%.The investment community will be paying close attention to the earnings perf ...